Sanofi (SNY) EBIT (QoQ) (2009 - 2026)
Sanofi (SNY) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.08 Bn | 633.32 Bn | 17.26 Bn |
| 2 | AbbVie | 470.80 Bn | 464.23 Bn | 12.70 Bn |
| 3 | Merck | 377.96 Bn | 370.82 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.49 Bn | 295.80 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.97 Bn | 253.07 Bn | 12.86 Bn |
| 6 | Amgen | 236.98 Bn | 222.99 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.41 Bn | 179.23 Bn | 6.22 Bn |
| 8 | Pfizer | 159.49 Bn | 147.79 Bn | 10.94 Bn |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn |
| 10 | Sanofi | 55.08 Bn | 47.70 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.96% |
| Mar 31, 2026 | 18.08% |
| Dec 31, 2025 | -72.50% |
| Sep 30, 2025 | 225.04% |
| Jun 30, 2025 | 9.34% |
| Mar 31, 2025 | -47.29% |
| Dec 31, 2024 | 59.91% |
| Sep 30, 2024 | 23.49% |
| Jun 30, 2024 | 3.69% |
| Mar 31, 2024 | -76.05% |
| Dec 31, 2023 | 235.24% |
| Sep 30, 2023 | 12.70% |
| Jun 30, 2023 | -1.39% |
| Mar 31, 2023 | -68.04% |
| Dec 31, 2022 | 190.89% |
| Sep 30, 2022 | 10.31% |
| Jun 30, 2022 | 0.96% |
| Mar 31, 2022 | -64.93% |
| Dec 31, 2021 | 165.12% |
| Sep 30, 2021 | 11.55% |